MaxCyte, Inc. Other Non-Current Assets
MaxCyte, Inc. (MXCT) had Other Non-Current Assets of $1.03 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Noncurrent $1.03M.
- 2026-03-31: Other Assets, Noncurrent $2.61M.
- 2025-12-31: Other Assets, Noncurrent $2.47M.
- 2025-09-30: Other Assets, Noncurrent $2.58M.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.61M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $2.47M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $2.58M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.80M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.91M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.53M 10-K · filed 2026-03-25 |
| 2024-09-30 | $1.05M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $640.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $295.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $388.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $619.40K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $597.30K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $399.30K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $809.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $1.19M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $920.50K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.05M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $316.70K 10-K · filed 2023-03-15 |
| 2021-09-30 | $318.10K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.70M 10-Q · filed 2021-09-13 |
| 2020-12-31 | $33.90K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |